The US Food and Drug Administration named Dexcom as the first manufacturer selected for its Technology-Enabled Meaningful Patient Outcomes pilot on Tuesday. The programme, known as TEMPO, allows digital health devices to be offered to Medicare patients before the agency has authorised them for t...
Source: [TNW](https://thenextweb.com/news/fda-tempo-pilot-dexcom-first-participant-enforcement-discretion)